Switzerland
Research Article
Trigeminal Neuralgia Type 1: Earlier Microvascular Decompression is Associated with Improved Outcome
Author(s): Doortje C Engel, Jean-Yves Fournier, Cem Yetimoglu and Sarah R HaileDoortje C Engel, Jean-Yves Fournier, Cem Yetimoglu and Sarah R Haile
Background: Medication therapy is commonly accepted as the initial treatment of trigeminal neuralgia (TN). Microvascular decompression (MVD) is the surgical treatment with the highest efficacy, but is considered as last tier therapy for patients with medication refractory pain or for those with unbearable side effects. The aim of this study was to investigate the association of symptom duration on outcome. Methods: A retrospective study was conducted from 2001 through 2012. Patients were categorized according to Burchiel’s “Classification scheme for facial pains commonly encountered in neurosurgical practice”. Demographical, disease and treatment data as well as surgical data including complications and outcome were recorded and analyzed. Results: In total, 65 patients were included. Distribution of diagn.. Read More»
DOI:
10.4172/2376-0281.1000307
International Journal of Neurorehabilitation received 1078 citations as per Google Scholar report